B Englich1, G Herberth1, U Rolle-Kampczyk2, S Trump1, S Röder1, M Borte3, G I Stangl4, M von Bergen2,5, I Lehmann1, K M Junge1. 1. Helmholtz Centre for Environmental Research (UFZ), Department of Environmental Immunology, Leipzig, Germany. 2. Helmholtz Centre for Environmental Research (UFZ), Department of Systems Biology, Leipzig, Germany. 3. Children's Hospital, Municipal Hospital 'St Georg', Leipzig, Germany. 4. Martin Luther University Halle-Wittenberg, Institute of Agricultural and Nutritional Sciences, Halle (Saale), Germany. 5. University of Leipzig, Faculty of Biosciences, Pharmacy and Psychology, Institute of Biochemistry, Department of Functional Proteome Analytics, Leipzig, Germany.
Abstract
BACKGROUND: The maternal inflammation status during pregnancy has been associated with metabolic imprinting and obesity development in the child. However, the influence of the maternal Th2 cytokines, interleukin-4 (IL4), IL5 and IL13, has not been studied so far. METHODS: We investigated the relationship between maternal innate (IL6, IL8, IL10 and tumor necrosis factor-α (TNFa)) and adaptive (interferon-γ, IL4, IL5 and IL13) blood cytokine levels at 34 weeks of gestation and children's overweight development until the age of 3 years in 407 children of the German longitudinal LINA (Lifestyle and Environmental Factors and their Influence on Newborns Allergy risk) cohort. Children's body weight and height were measured during the annual clinical visits or acquired from questionnaires. Body mass index (BMI) Z-scores were calculated according to the WHO reference data to adjust for child's age and gender. Cytokine secretion was stimulated with phytohemagglutinin or lipopolysaccharide and measured by cytometric bead assay. Furthermore, we assessed metabolic parameter in blood of 318 children at age 1 using the AbsoluteIDQ p180 Kit (Biocrates LIFE Science AG). RESULTS: Applying logistic regression models, we found that an increase of maternal IL4 and IL13 was associated with a decreased risk for overweight development in 1- and 2-year-old children. This effect was consistent up to the age of 3 years for IL13 and mainly concerns children without maternal history of atopy. Children's acylcarnitine concentrations at 1 year were positively correlated with maternal IL13 levels and inversely associated with the BMI Z-score at age 1. CONCLUSIONS: We were able to show for the first time that the maternal Th2 status may be linked inversely to early childhood overweight development accompanied by an altered metabolic profile of the fetus. However, our data do not support a direct mediating role of acylcarnitines on maternal IL13-induced weight development.
BACKGROUND: The maternal inflammation status during pregnancy has been associated with metabolic imprinting and obesity development in the child. However, the influence of the maternal Th2 cytokines, interleukin-4 (IL4), IL5 and IL13, has not been studied so far. METHODS: We investigated the relationship between maternal innate (IL6, IL8, IL10 and tumor necrosis factor-α (TNFa)) and adaptive (interferon-γ, IL4, IL5 and IL13) blood cytokine levels at 34 weeks of gestation and children's overweight development until the age of 3 years in 407 children of the German longitudinal LINA (Lifestyle and Environmental Factors and their Influence on Newborns Allergy risk) cohort. Children's body weight and height were measured during the annual clinical visits or acquired from questionnaires. Body mass index (BMI) Z-scores were calculated according to the WHO reference data to adjust for child's age and gender. Cytokine secretion was stimulated with phytohemagglutinin or lipopolysaccharide and measured by cytometric bead assay. Furthermore, we assessed metabolic parameter in blood of 318 children at age 1 using the AbsoluteIDQ p180 Kit (Biocrates LIFE Science AG). RESULTS: Applying logistic regression models, we found that an increase of maternal IL4 and IL13 was associated with a decreased risk for overweight development in 1- and 2-year-old children. This effect was consistent up to the age of 3 years for IL13 and mainly concerns children without maternal history of atopy. Children's acylcarnitine concentrations at 1 year were positively correlated with maternal IL13 levels and inversely associated with the BMI Z-score at age 1. CONCLUSIONS: We were able to show for the first time that the maternal Th2 status may be linked inversely to early childhood overweight development accompanied by an altered metabolic profile of the fetus. However, our data do not support a direct mediating role of acylcarnitines on maternal IL13-induced weight development.
Authors: Andreas Oberbach; Matthias Blüher; Henry Wirth; Holger Till; Peter Kovacs; Yvonne Kullnick; Nadine Schlichting; Janina M Tomm; Ulrike Rolle-Kampczyk; Jayaseelan Murugaiyan; Hans Binder; Arne Dietrich; Martin von Bergen Journal: J Proteome Res Date: 2011-08-29 Impact factor: 4.466
Authors: Ji Young Kim; Ju Yeon Park; Oh Yoen Kim; Bo Mi Ham; Hyun-Jin Kim; Dae Young Kwon; Yangsoo Jang; Jong Ho Lee Journal: J Proteome Res Date: 2010-09-03 Impact factor: 4.466
Authors: Sean H Adams; Charles L Hoppel; Kerry H Lok; Ling Zhao; Scott W Wong; Paul E Minkler; Daniel H Hwang; John W Newman; W Timothy Garvey Journal: J Nutr Date: 2009-04-15 Impact factor: 4.798
Authors: Stephanie J Mihalik; Sara F Michaliszyn; Javier de las Heras; Fida Bacha; SoJung Lee; Donald H Chace; Victor R DeJesus; Jerry Vockley; Silva A Arslanian Journal: Diabetes Care Date: 2012-01-20 Impact factor: 19.112
Authors: Jai Woo Lee; Erika L Moen; Tracy Punshon; Anne G Hoen; Delisha Stewart; Hongzhe Li; Margaret R Karagas; Jiang Gui Journal: Comput Biol Med Date: 2019-08-31 Impact factor: 4.589
Authors: Lisa F Stinson; Melvin C L Gay; Petya T Koleva; Merete Eggesbø; Christine C Johnson; Ganesa Wegienka; Elloise du Toit; Naoki Shimojo; Daniel Munblit; Dianne E Campbell; Susan L Prescott; Donna T Geddes; Anita L Kozyrskyj Journal: Front Immunol Date: 2020-07-21 Impact factor: 7.561
Authors: Miguel A Ortega; Ana M Gómez-Lahoz; Lara Sánchez-Trujillo; Oscar Fraile-Martinez; Cielo García-Montero; Luis G Guijarro; Coral Bravo; Juan A De Leon-Luis; Jose V Saz; Julia Bujan; Natalio García-Honduvilla; Jorge Monserrat; Melchor Alvarez-Mon Journal: Int J Mol Sci Date: 2022-08-11 Impact factor: 6.208
Authors: Rachel L Maguire; John S House; Dillon T Lloyd; Harlyn G Skinner; Terrence K Allen; Asifa Mohamed Raffi; David A Skaar; Sarah S Park; Lauren E McCullough; Scott H Kollins; Staci D Bilbo; David N Collier; Susan K Murphy; Bernard F Fuemmeler; Kymberly M Gowdy; Cathrine Hoyo Journal: Pediatr Obes Date: 2020-12-30 Impact factor: 3.910
Authors: M Isabel Ordiz; Richard D Semba; Ruin Moaddel; Ulrike Rolle-Kampczyk; Martin von Bergen; Gunda Herberth; Mohammed Khadeer; Stefan Röder; Mark J Manary Journal: Curr Dev Nutr Date: 2019-08-29